Latest News

July 10, 2013
A new study by UCSF researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless experience life-shortening chronic diseases.
June 25, 2013
Two veteran UCSF doctors who have been battling the AIDS epidemic for decades retraced past efforts and described their ongoing quest for a cure for HIV in the Academic Senate’s Third Annual Faculty Research Lecture.
May 13, 2013
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
March 05, 2013
Community intervention with free mobile HIV testing and counseling, same-day results and post-test support led to a 14 percent reduction in new HIV infections in targeted communities in Sub-Saharan Africa, according to results of a large randomized, controlled trial.
November 30, 2012
UCSF and the Gladstone Institutes will observe World AIDS Day on December 3 with a symposium featuring emerging investigators working to combat the disease.
October 23, 2012
Global health pioneer Paul Farmer, MD, PhD, addressed a packed UCSF auditorium in a special lecture about a community-based health care model that his nonprofit organization, Partners In Health, has brought to some of the world's most impoverished countries, including Haiti and Rwanda.
October 16, 2012
The National Institutes of Health has awarded more than $15 million over the next five years to the UCSF-Gladstone Center for AIDS Research (CFAR) to continue its pioneering translational AIDS research.
October 02, 2012
Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
September 14, 2012
Scientists at the UCSF-affiliated Gladstone Institutes have devised a method to track HIV inside individual cells — an important development for understanding “HIV latency" when the virus goes dormant after the patient begins antiretroviral treatment.
September 12, 2012
New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada — the first and only medication approved by the FDA for HIV prevention.

Pages